J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
J7309 is a HCPCS Level II code for methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J7309 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7309
- Long descriptor
- Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- Short descriptor
- Methyl aminolevulinate, top
- Added
- January 1, 2011
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7309
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7309 is not quite right, the correct code is very often within a few positions of it.
- J7300Intrauterine copper contraceptive (paragard)
- J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mgterminated
- J7303Contraceptive supply, hormone containing vaginal ring, eachterminated
- J7304Contraceptive supply, hormone containing patch, each
- J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7310Ganciclovir, 4.5 mg, long-acting implantterminated
- J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
- J7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
- J7315Mitomycin, ophthalmic, 0.2 mg
- J7316Injection, ocriplasmin, 0.125 mg
- J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
Questions about J7309
What is HCPCS code J7309?
J7309 is a HCPCS Level II code for methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7309?
The CMS HCPCS file marks J7309 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J7309 still valid?
No. J7309 was terminated on December 31, 2025 and should not be used on new claims.